See analyst estimates and all valuation multiples for Genomics & Personalized Medicine
Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
$20.7B | 11.4x | -85.5x | |
$14.4B | 3.3x | 12.5x | |
$12.4B | 4.3x | 33.3x | |
$5.6B | 7.1x | -23.2x | |
$2.5B | 4.5x | 80.1x | |
$2.1B | 2.4x | 13.6x | |
$2.0B | 6.0x | 84.9x | |
$1.8B | 4.0x | 18.6x | |
$1.6B | 4.4x | -11.3x | |
$949M | 1.5x | 16.1x | |
$827M | 1.4x | -5.4x | |
$771M | 5.7x | -0.7x | |
$745M | 2.1x | 25.3x | |
$644M | 4.2x | -3.0x | |
$599M | 2.0x | 11.3x | |
$524M | 66.9x | -5.7x | |
$454M | 0.5x | 13.9x | |
$425M | 6.7x | n/a | |
$318M | 1.1x | -31.0x | |
$291M | n/a | n/a | |
$268M | 3.2x | -3.9x | |
$259M | 24.9x | n/a | |
$241M | 106.7x | -13.9x | |
$240M | 70.2x | n/a | |
$239M | 48.5x | -61.5x | |
$225M | n/a | n/a | |
$212M | 0.7x | 4.6x | |
$163M | 2.4x | -4.0x | |
$158M | 1.1x | -0.7x | |
$158M | n/a | n/a | |
$132M | 18.9x | -0.7x | |
$118M | 24.6x | -0.6x | |
$114M | 2.0x | -1.6x | |
$56.4M | 82.3x | -0.3x | |
$38.3M | 14.9x | n/a | |
$36.4M | n/a | -0.4x | |
$35.0M | 0.7x | 5.4x | |
$16.8M | n/a | n/a | |
$12.4M | 0.4x | -0.2x | |
$8.0M | n/a | n/a | |
$7.4M | n/a | -0.1x | |
$6.1M | 0.1x | -0.2x | |
$3.1M | 0.1x | -0.0x | |
$16K | n/a | -0.0x | |
-$0.4M | n/a | 0.0x | |
-$1.8M | -1.4x | 0.0x | |
-$2.7M | n/a | n/a | |
-$11.1M | n/a | n/a | |
-$30.9M | -0.8x | 0.1x | |
-$35.6M | n/a | 0.2x | |
-$43.0M | -0.7x | 0.4x | |
-$44.8M | -2.5x | n/a | |
-$45.4M | -1.8x | 0.2x | |
-$67.2M | -1.4x | n/a | |
-$83.7M | -8.4x | 0.5x | |
-$118M | -2.7x | 1.2x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Genomics & Personalized Medicine